"Link Between Decades-Old Medical Treatments and Alzheimer's Transmission Uncovered"

A recent study suggests a potential link between past medical treatment with contaminated human growth hormone and the early onset of Alzheimer’s disease in five individuals, highlighting the importance of preventing accidental amyloid-beta transmission in medical procedures. The study reports that individuals treated with cadaver-derived human growth hormone (c-hGH) between 1959 and 1985 may have developed Alzheimer's disease due to transmission of the amyloid-beta protein. The findings underscore the need to review measures to prevent accidental transmission of amyloid-beta via other medical or surgical procedures and may provide valuable insights into disease mechanisms for understanding and treating Alzheimer’s disease in the future.